Skip to main content
MANNKIND CORP logo

MANNKIND CORP — Investor Relations & Filings

Ticker · MNKD ISIN · US56400P7069 LEI · 213800GFBCNY1ZFST722 US Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2012-05-29 Director's Dealing
Country US United States of America
Listing US MNKD

About MANNKIND CORP

https://mannkindcorp.com/

MannKind Corporation is a biopharmaceutical company focused on the development and commercialization of therapeutic products and devices. The company specializes in inhaled therapies for patients with cardiometabolic and orphan lung diseases. Its portfolio includes Afrezza®, an inhaled insulin for diabetes, and Tyvaso DPI®, a dry powder inhaler for pulmonary hypertension developed in collaboration with United Therapeutics. Through its acquisition of scPharmaceuticals, MannKind also markets FUROSCIX®, a subcutaneous treatment for edema in adults with chronic heart failure. The company's pipeline is focused on expanding indications for its existing products, including a pediatric application for Afrezza.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2012-05-29 English
FORM 8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about the departure and election of directors, approval of amendments to equity incentive plans, voting results from the annual meeting, and equity awards to executives. It also includes tabulated voting results and references to exhibits such as the Certificate of Amendment and the Equity Incentive Plan. The key focus is on changes in the board and management, equity awards, and shareholder voting outcomes. This aligns with announcements about board/management changes and voting results. However, since the document includes detailed voting results and matters submitted to a vote of security holders, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not merely announcing a report publication, nor is it a full annual report or proxy statement. It is a current report with detailed voting results and management changes. Therefore, the appropriate classification is DVA with high confidence.
2012-05-22 English
FORM 4 SUBMISSION
Director's Dealing
2012-05-22 English
FORM 4 SUBMISSION
Director's Dealing
2012-05-22 English
FORM 4 SUBMISSION
Director's Dealing
2012-05-22 English
FORM 4 SUBMISSION
Director's Dealing
2012-05-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.